Evidence map›Paper›PMID 34604569›Full record

ArticleJournal of preventive medicine and hygiene2021

Epidemiological and clinical characteristics of the COVID-19 epidemic and associated factors for mortality in Golestan province, Iran: a retrospective cohort study.

Mohammad Reza Honarvar, Gholamreza Roshandel, Hesamaddin Shirzad-Aski, Alijan Tabarraei, Alireza Tahamtan, Mousa Ghelichi-Ghojogh, Abdolreza Fazel, Serajeddin Arefnia, Nahid Jafari, Mohsen Mansoury and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of preventive medicine and hygiene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The Comparison of Clinical Epidemiology of Hospitalized Patients with COVID-19 during the Third and Fourth Waves of the Pandemic in Gorgan.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Mohammad Reza HonarvarHealth Management and Social Development Research Center, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Gholamreza RoshandelGolestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Hesamaddin Shirzad-AskiInfectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Alijan TabarraeiDepartment of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Alireza TahamtanDepartment of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Mousa Ghelichi-GhojoghDepartment of Epidemiology, Faculty of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Abdolreza FazelCancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Serajeddin ArefniaDeputy of Treatment, Golestan University of Medical Sciences, Gorgan, Iran.
Nahid JafariDeputy of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Mohsen MansouryStatistics and Information Technology Office, Golestan University of Medical Sciences, Gorgan, Iran.
Alireza JafariSocial Determinants of Health Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.
Abdolhalim RajabiHealth Management and Social Development Research Center, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.
Golestan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia and risk factors associated for mortality.

methodsIn this study, we included inpatient with acute respiratory distress syndrome at Golestan Hospitals who had been discharged or had died in 2020. Epidemiological, and clinical data were extracted from electronic medical records and compared between recovered and died cases. We used multiple logistic regression methods to explore the risk factors associated with in-hospital death.

resultsOverall 2,835 acute respiratory distress syndrome patients were included in this study, and 874 (30.83%) were positive for 2019-nCoV. Five hundred and sixty-three patients (19.86%) died, 1,687 patients (59.51%) were recovered. Of the total deaths, only 288 (10.15%) were attributed to COVID-19. The most common symptoms at onset of illness were respiratory distress [1,795 (63.32%)], fever [1,601 (56.47%)], dry cough [1,595 (56.26%)], sore throat [445 (15.70%)], and myalgia [342 (12.06%)]. One thousand and twelve (35.7%) had 1 or more coexisting medical conditions. In multiple logistic regression analysis, risk factors associated with the death included older age [OR (Odds Ratio) = 1.03; 95% CI; 1.02-1.04], blood oxygen level (SPO

conclusionsThe 2019-nCoV infection caused collections of severe respiratory illness and was associated to a high ratio of hospitalization in ICU and high mortality. Older age and comorbidities were associated with more risk of death among patients with 2019-nCoV.

Indexed as

PandemicsAdultAgedAged, 80 and overAge FactorsComorbidityCOVID-19FemaleHospitalizationHospital MortalityHumansIranMaleMiddle AgedRespiratory Distress SyndromeRetrospective StudiesAcute Respiratory Distress SyndromeCOVID-19DeathIran

Identifiers

PMID34604569
PMCPMC8451345
OpenAlexW3196170958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.